Deals

Baxano Surgical Raises $10M via Conv Debt Deal at 20% Discount via Piper Jaffray, Stifel

By |

Baxano Surgical, Inc. (BAXS) announced that it has raised $10,000,000 in a Convertible Subordinated Debentures transaction. The fixed conversion price of the Convertible Subordinated Debentures is $1.06 per share, an approximate 20.3% discount to the market price ($1.33) of BAXS at deal announcement. A series of 9,428,000 36-Month Warrants with an exercise price of $1.19 per share (10.53% discount) was issued to the investors in this transaction. Piper Jaffray acted as Lead Placement Agent with Stifel Nicolaus Weisel as Co-Agent on the transaction. via PlacementTracker.

Deals

Can-Fite BioPharma Raises $5M at 12% Discount via Roth Capital

By |

Can-Fite BioPharma Limited (CANF) announced that it has raised $5,059,072 in a Common Stock transaction. The common stock was sold at $5.15 per share, an approximate 12% discount to the market price ($5.85) of CANF at deal announcement. A series of 491,172 4.5-Month Warrants with an exercise price of $6.43 per share (9.91% premium) was issued to the investors in this transaction. Roth Capital Partners acted as the exclusive agent on the transaction. Placement Agent counsel was Schulte Roth & Zabel and issuer counsel was Sichenzia Ross Friedman Ference.

Deals

Immune Pharmaceuticals Raises $11.7M in Conv Preferred Deal at 15% Discount via Chardan Capital

By |

Immune Pharmaceuticals Inc. (IMNP) announced that it has raised $11,700,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $3.40 per share, an approximate 14.79% discount to the market price ($3.99) of IMNP at deal announcement. A series of 5,850 60-Month Warrants with an exercise price of $4.25 per share was issued to the investors in this transaction. An additional series of 5,850 60-Month Warrants with an exercise price of $5.10 per share was issued to the investors in this transaction.Chardan Capital Markets acted as the exclusive agent on the transaction. Issuer counsel was Greenberg Traurig.